Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Boehringer Ingelheim
Related studies linked through entity extraction aliases.
Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Dose Tolerance Study in Healthy Male Volunteers After Intranasal Application of Epinastine Nasal
- Status
- COMPLETED
- Phase
- PHASE1
In Vitro/in Vivo Correlation (IVIVC) for Oral Slow Release (SR) Tablets Pramipexole in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to the Market Standard, Atrovent® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Food on the Bioavailability and Pharmacokinetic Profile of Itasetron After a Single Oral Dose in Healthy Male Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 113823 Powder in Bottle (PiB) and Tablet in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of KUC 7483 CL Tablets in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study to Investigate the Regional Drug Absorption of KUC-7483 CL Administered Via an Enterion™ Capsule Compared to an Immediate Release Formulation in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Pharmacokinetics, and Pharmacodynamics of BIRT 2584 XX in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of New Tablet Formulations and Suspension Formulation Compared to Current (1B) Formulation of BILR 355 BS in Healthy Male Volunteer Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers
- Status
- COMPLETED
- Phase
- PHASE1